Camlin Fine Sciences (CAMLINFINE) provided an update on its plan to acquire a majority stake in Vinpai S.A.

The deal's completion timeline is now extended to November 30, 2025, from the earlier September 30. The delay was primarily due to foreign sellers needing to secure Permanent Account Number (PAN) documents, which are now in place.

CAMLINFINE plans to issue new equity shares through a preferential allotment as payment for the stake, awaiting Board and Shareholder approvals.

This clarifies the path forward for the acquisition.